Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Oasmia Pharmaceutical AB | 3,685,578 | net | 13 Jul 2023 | tx 1+3,685,578 |
| NeuroVive Pharmaceutical AB | 744,572 | net | 29 Apr 2020 | tx 10+765,954−21,382 |
| Sprint Bioscience AB | 200,000 | net | 15 Nov 2022 | tx 2+200,000 |
| Stayble Therapeutics AB | 7,731 | net | 16 Jul 2020 | tx 3+7,731 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Jul 2023 | GRANT_AWARD | Oasmia Pharmaceutical AB | 3,685,578 | 0.00 SEK | deriv |
| 15 Nov 2022 | PURCHASE | Sprint Bioscience AB | 100,000 | 0.75 SEK | first after silence |
| 08 Sept 2021 | PURCHASE | Sprint Bioscience AB | 100,000 | 5.34 SEK | first after silence |
| 15 Jul 2020 | PURCHASE | Stayble Therapeutics AB | 2,572 | 12.41 SEK | |
| 14 Jul 2020 | PURCHASE | Stayble Therapeutics AB | 1,744 | 12.41 SEK | |
| 16 Jul 2020 | PURCHASE | Stayble Therapeutics AB | 3,415 | 12.41 SEK | |
| 29 Apr 2020 | PURCHASE | NeuroVive Pharmaceutical AB | 200,149 | 0.80 SEK | |
| 03 Sept 2019 | PURCHASE | NeuroVive Pharmaceutical AB | 21,382 | 1.60 SEK | |
| 02 Sept 2019 | SALE | NeuroVive Pharmaceutical AB | 21,382 | 1.66 SEK | |
| 06 Feb 2019 | PURCHASE | NeuroVive Pharmaceutical AB | 200,149 | 1.35 SEK | |
| 21 Dec 2018 | PURCHASE | NeuroVive Pharmaceutical AB | 44,901 | 1.32 SEK | |
| 27 Dec 2018 | PURCHASE | NeuroVive Pharmaceutical AB | 73,000 | 1.30 SEK | |
| 25 Apr 2018 | PURCHASE | NeuroVive Pharmaceutical AB | 8,812 | 8.00 SEK | |
| 23 Feb 2017 | PURCHASE | NeuroVive Pharmaceutical AB | 8,600 | 5.62 SEK |
2 purchases reported after at least 12 months of silence — most recent on 15 Nov 2022.